N/A
N=50
Stool Sampling in the Acute Isolated Patient , Efficient Acquiring With a Novel Device
Feasibility Study
Bottom Line
View on ClinicalTrials.gov: NCT06495775 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Number of Participants With Stool Sample Acquired — 46 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- quickfact (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Zealand University Hospital
- Primary completion
- Jul 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Stool Sample Acquired |
46 | — |
| PRIMARY Safety of Device |
50 | — |
Summary
stool sample device tested on patients admitted to oncological dept. with diarrhea, in order to shorten time in isolation and time to relevant treatment.
Eligibility Criteria
Inclusion Criteria
- Understanding Danish
- admitted to dept og oncology with diarrhea
- cognitive intact
- Co operable to fecal sampling
Exclusion Criteria
- expected survival less than 2 weeks
Data sourced from ClinicalTrials.gov (NCT06495775). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.